CureVac, which said earlier this week that it planned to raise up to $245m on Nasdaq to accelerate the development of its Covid-19 vaccine, is expected to price its initial public offering after the …
( read original story …)
The Shanghai News
CureVac, which said earlier this week that it planned to raise up to $245m on Nasdaq to accelerate the development of its Covid-19 vaccine, is expected to price its initial public offering after the …
( read original story …)